CSL324 Recruiting Phase 1 Trials for Palmoplantar Pustulosis (PPP) / Hidradenitis Suppurativa (HS) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03972280Safety and Pharmacokinetics of Repeat Doses of CSL324 in Subjects With Hidradenitis Suppurativa and Palmoplantar Pustulosis